Article Text

Download PDFPDF

Meige syndrome: double-blind crossover study of sodium valproate.
  1. J W Snoek,
  2. T W van Weerden,
  3. A W Teelken,
  4. W van den Burg,
  5. J P Lakke
  1. Department of Neurology, University Hospital, Groningen, The Netherlands.


    A double-blind crossover study of sodium valproate and placebo was conducted in five patients with Meige syndrome. CSF neurotransmitter studies were performed at the end of each treatment period. GABA levels were not influenced by the administration of sodium valproate. An increase in HVA levels was observed in every patient, which may reflect an increase in central dopaminergic activity. This finding may explain the trend towards clinical deterioration which was observed during treatment with sodium valproate. Sodium valproate appears to be ineffective in Meige syndrome.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.